Janus Henderson Group
BCAB icon

Janus Henderson Group’s BioAtla BCAB Stock Holding History

Janus Henderson Group’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-39,657
Closed -$16.4M – 2689
2022
Q4 		$16.4M Sell
39,657
-47,332
-54% -$19.6M 0.01% 608
2022
Q3 		$33.5M Buy
86,989
+40,213
+86% +$13.2M 0.01% 585
2022
Q2 		$6.67M Sell
46,776
-4,518
-9% -$719K ﹤0.01% 784
2022
Q1 		$12.8M Buy
51,294
+16,501
+47% +$6.9M 0.01% 845
2021
Q4 		$34.2M Buy
34,793
+198
+0.6% +$253K 0.01% 657
2021
Q3 		$50.9M Buy
34,595
+14,542
+73% +$28.3M 0.02% 547
2021
Q2 		$42.5M Sell
20,053
-595
-3% -$1.34M 0.02% 615
2021
Q1 		$52.5M Sell
20,648
-5,676
-22% -$14.5M 0.02% 535
2020
Q4 		$44.8M Buy
+26,324
New +$44M 0.02% 569

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group's BCAB Position: Q1 2023 in Review

Janus Henderson Group sold out of BioAtla (BCAB) in Q1 2023, closing a stake of 39,657 shares — an estimated $16.4M sold.

Janus Henderson Group first reported a position in BCAB in Q4 2020 and held it in 9 quarters. The position peaked at $52.5M in Q1 2021. 79 funds tracked by Wall St. Rank hold BCAB as of Q1 2023.

  • Janus Henderson Group reported no remaining BioAtla position as of Q1 2023 after selling out during the quarter.
  • Janus Henderson Group sold 39,657 BioAtla shares in Q1 2023, an estimated $16.4M.
  • Janus Henderson Group first reported a position in BioAtla in Q4 2020 and held it in 9 quarters.
  • Janus Henderson Group's BioAtla position peaked at $52.5M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held BioAtla as of Q1 2023.

Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.